Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-01-12

FDA Approved: AMANTADINE — Supplemental Application (AvPAK)

View source ↗

Summary

The FDA approved a supplemental application for Amantadine from AvPAK under an ANDA. This action updates the regulatory status of this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

SUPPL AP for AMANTADINE (AMANTADINE)